Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | EPHX1 | P07099 | 1/20 | 0.39 |
| ▸ | TLR8 | Q9NR97 | 2/20 | 0.35 |
| ▸ | POLB | P06746 | 1/20 | 0.31 |
| ▸ | DRD2 | P14416 | 1/20 | 0.31 |
| ▸ | HRH2 | P25021 | 1/20 | 0.31 |
| ▸ | HRH1 | P35367 | 1/20 | 0.31 |
| ▸ | DRD3 | P35462 | 1/20 | 0.31 |
| ▸ | HRH4 | Q9H3N8 | 1/20 | 0.31 |
| ▸ | HRH3 | Q9Y5N1 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL19970383 | 1.00 | EPHX1 (0.39) | EPHX1TLR8POLBDRD2HRH2 | |
| SCHEMBL19970373 | 0.89 | TLR8 (0.38) | TLR8POLB | |
| SCHEMBL19970370 | 0.89 | TLR8 (0.38) | TLR8POLB | |
| SCHEMBL19975877 | 0.89 | TLR8 (0.38) | TLR8POLB | |
| SCHEMBL19977079 | 0.86 | CSNK2A2 (0.36) | TLR8DRD2 | |
| SCHEMBL19970390 | 0.83 | POLB (0.32) | TLR8POLB | |
| SCHEMBL19970384 | 0.83 | POLB (0.32) | TLR8POLB | |
| Bromide SCHEMBL19970379 | 0.82 | EPHX1 (0.37) | EPHX1 | |
| Bromide SCHEMBL19970376 | 0.82 | EPHX1 (0.37) | EPHX1 | |
| Bromide SCHEMBL19970432 | 0.81 | EPHX1 (0.36) | EPHX1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3512604-B1 | STABLE YELLOW IMIDAZOLIUM COMPOUNDS AND METHODS FOR THEIR USE | WELLA OPERATIONS US LLC (US) | 2023-05-31 | — | — | EP | disclosed |
| EP-3512604-A1 | STABLE YELLOW IMIDAZOLIUM COMPOUNDS AND METHODS FOR THEIR USE | Noxell Corporation (US) | 2019-07-24 | — | — | EP | disclosed |
| US-10093807-B2 | Stable yellow imidazolium compounds | NOXELL CORPORATION (US) | 2018-10-09 | — | — | US | disclosed |
| WO-2018053027-A1 | STABLE YELLOW IMIDAZOLIUM COMPOUNDS AND METHODS FOR THEIR USE | NOXELL CORPORATION (US) | 2018-03-22 | — | — | WO | disclosed |
| US-20180079907-A1 | Stable Yellow Imidazolium Compounds | WELLA OPERATIONS US, LLC | 2018-03-22 | — | — | US | disclosed |
| US-20180078477-A1 | Method of Coloring Hair with Washfast Yellow Imidazolium Direct Dye Compounds | WELLA OPERATIONS US, LLC | 2018-03-22 | — | — | US | disclosed |
| US-9918919-B1 | Method of coloring hair with washfast yellow imidazolium direct dye compounds | NOXELL CORPORATION (US) | 2018-03-20 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20180078477-A1 | Method of Coloring Hair with Washfast Yellow Imidazolium Direct Dye Compounds | WASHC4, TYR, WASHC5 | EPHX1 1896/4885TLR8 3142/4885POLB 1492/4885 |
| US-10093807-B2 | Stable yellow imidazolium compounds | IK, NDUFV1, NDUFV2 | EPHX1 4558/4885TLR8 3446/4885POLB 1469/4885 |
| US-20180079907-A1 | Stable Yellow Imidazolium Compounds | IK, NDUFV1, NDUFV2 | EPHX1 4558/4885TLR8 3446/4885POLB 1469/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.